Whole-body protein metabolism in chronic heart failure: relationship to anabolic and catabolic hormones

Journal of Parenteral and Enteral Nutrition

Volumn 30, Issue 3, 2006, Pages 194-201

  Toth, Michael J ^a,b   Matthews, Dwight E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; LEUCINE; PROTEIN;

AGED; ARTICLE; BASAL METABOLIC RATE; BLOOD; BODY COMPOSITION; CACHEXIA; CASE CONTROL STUDY; CONGESTIVE HEART FAILURE; ENERGY METABOLISM; HUMAN; MALE; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; OXYGEN CONSUMPTION; PHYSIOLOGY;

AGED; BASAL METABOLISM; BODY COMPOSITION; CACHEXIA; CARBON ISOTOPES; CASE-CONTROL STUDIES; ENERGY METABOLISM; HEART FAILURE, CONGESTIVE; HUMANS; LEUCINE; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; PROTEINS;

EID: 33748351378     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607106030003194     Document Type: Article

References (47)

1. Pitman JG, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med. 1964;271:403-409.
2. Rich MW, Keller AJ, Schechtman KB, Marshall WG, Kouchou-kos NT. Increased complications and prolonged hospital stay in elderly cardiac surgical patients with low serum albumin. Am J Cardiol. 1989;63:714-718.
3. Blackburn GL, Gibbons GW, Bothe A, Benotti PN, Harken DE, McEnany TM. Nutritional support in cardiac cachexia. J Thoracic Cardiovasc Surg. 1977;73:489-494.
4. Abel RM, Fischer JE, Buckley MJ, Barnett O, Austen WJ. Malnutrition in cardiac surgical patients: results of a prospective, randomized evaluation of early postoperative parenteral nutrition. Arch Surg. 1976;111:45-50.
5. Toth MJ, Gottlieb SS, Fisher ML, Poehlman ET. Skeletal muscle atrophy and peak oxygen consumption in heart failure. Am J Cardiol. 1997;79:1267-1269.
6. Harrington D, Anker S, Chua TP, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol. 1997;30:1758-1764.
7. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050-1053.
8. Gosker HR, Wouters EFM, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanims and therapy perspectives. Am J Clin Nutr. 2000;71:1033-1047.
9. Niebauer J, Pflaum CD, Clark AL, et al. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohumoral activation. J Am Coll Cardiol. 1998;32:393-397.
10. Anker SD, Clark AL, Kemp M, et al. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol. 1997;30:997-1001.
11. Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96:526-534.
12. Anker SD, Ponikowski PP, Clark AL, et al. Cytokines and neu-rohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J. 1999;20:683-693.
13. Melville S, McNurlan MA, Calder AG, Garlick PJ. Increased protein turnover despite normal energy metabolism and responses to feeding in patients with lung cancer. Cancer Res. 1990;50:1125-1131.
14. 14C]-leucine. Surgery. 1980;88:294-300.
15. Kien CL, Young VR, Rohrbaugh DK, Burke JF. Increased rates of whole body protein synthesis and breakdown in children recovering from burns. Ann Surg. 1978;187:383-391.
16. Yarasheski KE, Zachwieja JJ, Gischler J, Crowley J, Horgan MM, Powderly WG. Increased plasma Gin and Leu Ra and inappropriately low muscle protein synthesis rates in AIDS wasting. Am J Physiol. 1998;275:E577-E583.
17. Rall LC, Rosen CJ, Dolnikowski G, et al. Protein metabolism in rheumatoid arthritis and aging: effect of muscle strength training and tumor necrosis factor alpha. Arthritis Rheum. 1996;39: 1115-1124.
18. Matthews DE, Battezzati A. Regulation of protein metabolism during stress. Curr Opin Gen Surg. 1993;72-77.
19. Brillon DJ, Zheng B, Campbell RG, Matthews DE. Effect of cortisol on energy expenditure and amino acid metabolism in humans. Am J Physiol. 1995;268:E501-E513.
20. Toth MJ, Matthews DE, Ades PA, et al. Skeletal muscle myofi-brillar protein metabolism in heart failure: relationship to immune activation and functional capacity. Am J Physiol. 2005; 288:E685-E692.
21. Matthews DE, Harkin R, Battezzati A, Brillon DJ. Splanchnic bed utilization of enteral alpha-ketoisocaproate in humans. Metab Clin Exp. 1999;48:1555-1563.
22. Matthews DE, Pesola G, Campbell RG. Effect of epinephrine on amino acid and energy metabolism in humans. Am J Physiol. 1990;258:E948-E956.
23. 2]leucine in healthy humans. Am J Physiol. 2001;281:E233-E241.
24. Kennedy RH, Ziegler MG. A more sensitive and specific radioen-zymatic assay for catecholamines. Life Sci. 1990;47:2143-2153.
25. Toth MJ, Sites CK, Cefalu WT, Matthews DE, Poehlman ET. Determinants of insulin-stimulated glucose disposal in middle-aged, premenopausal women. Am J Physiol. 2001;281:E113-E121.
26. Arciero PJ, Goran MI, Gardner AW, Ades PA, Tyzbir RS, Poehlman ET. A practical equation to predict resting metabolic rate in older men. Metabolism. 1993;42:950-957.
27. Riley M, Elborn JS, McKane WR, Bell N, Stanford CF, Nicholls DP. Resting energy expenditure in chronic cardiac failure. Clin Sci. 1991;80:633-639.
28. 2 data. J Appl Physiol. 1993;75:2288-2292.
29. Toth MJ, Gottlieb SS, Goran MI, Fisher ML, Poehlman ET. Daily energy expenditure in free-living heart failure patients. Am J Physiol. 1997;272:E469-E475.
30. Roubenoff R, Roubenoff RA, Cannon JG, et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest. 1993;93:2379-2386.
31. Grunfeld C, Pang M, Shimizu L, Shigenaga JK, Jensen P, Fein-gold KR. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr. 1992;55:455-460.
32. Macallan DC, McNurlan MA, Milne E, Calder AG, Garlick PJ, Griffin GE. Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection. Am J Clin Nutr. 1995;61:818-826.
33. Biolo G, Antonione R, Barazzoni R, Zanettic M, Guarnieri G. Mechanisms of altered protein turnover in chronic diseases: a review of human kinetic studies. Curr Opin Clin Nutr Metab Care. 2003;6:55-63.
34. Morrison WL, Gibson JNA, Rennie MJ. Skeletal muscle and whole body protein turnover in cardiac cachexia: influence of branched-chain amino acid administration. Eur J Clin Invest. 1988;18:648-654.
35. Cortes CW, Thompson PD, Moyna NM, et al. Protein kinetics in stable heart failure patients. J Appl Physiol. 2003;94:295-300.
36. Weinsier RL, Hunker EM, Krumdieck CL, Butterworth CE. Hospital malnutrition: a prospective evaluation of general medical patients during the course of hospitalization. Am J Clin Nutr. 1979;32:418-426.
37. Bettany GEA, Ang BC, Georgiannos SN, Halliday D, Powell-Tuck J. Bed rest decreases whole-body protein turnover in post-absorptive man. Clin Sci. 1996;90:73-75.
38. Stein TP, Rumpler WV, Leskiw MJ, Schluter MD, Staples R, Bodwell CE. Effect of reduced dietary intake on energy expenditure, protein turnover and glucose cycling in man. Metab Clin Exp. 1991;40:478-483.
39. Turkalj I, Keller U, Ninnis R, Vosmeer S, Stauffacher W. Effect of increasing doses of recombinant human insulin-like growth factor-1 on glucose, lipid and leucine metabolism in man. J Clin Endocr Metab. 1992;75:1186-1191.
40. Hussain' MA, Schmitz O, Mengel A, et al. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation and enhance insulin sensitivity. J Clin Invest. 1993;92:2249-2256.
41. Anker SD, Volterrani M, Pflaum CD, et al. Acquired growth hormone resistance in patients with chronic heart failure: impli- cations for therapy with growth hormone. J Am Coll Cardiol. 2001;38:443-452.
42. Strassmann G, Fong M, Kenney JS, Jacob CO. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest. 1992;89:1681-1684.
43. Tsujinaka T, Fujita J, Ebisui C, et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest. 1996;97: 244-249.
44. Jones SA, Rose-John S. The role of soluble receptors in cytokine biology: the agonist properties of the sIL-6R/IL-6 complex. Bio-chim Biophys Acta. 2002;1592:251-263.
45. Sakurai Y, Zhang XJ, Wolfe RR. TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. Am J Physiol. 1996;270:E864-E872.
46. Garcia-Martinez C, Llovera M, Lopez-Soriano FJ, del Santo B, Argiles JM. Lipopolysaccharide (LPS) increases the in vivo oxidation of branched-chain amino acids in the rat: a cytokine effect. Mol Cell Biochem. 1995;148:9-15.
47. Tsutamoto T, Hisanaga T, Wada A, et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 1998;31:391-398.